CBD (cannabidiol) has become a widely popular derivative of the hemp plant/cannabis plant (cannabis). To hugely oversimplify it: when you smoke cannabis, you are feeling the effects of two main cannabinoids. THC is the psychoactive component– the part that makes you "high." CBD is the more understated and bodily compo CBD American Shaman brings worldwide wellness through ultra-concentrated terpene rich CBD oil. Ships to all 50 States.
CBD (cannabidiol) has become a widely popular derivative of the hemp plant/cannabis plant (cannabis). To hugely oversimplify it: when you smoke cannabis, you are feeling the effects of two main cannabinoids. THC is the psychoactive component– the part that makes you “high.” CBD is the more understated and bodily component, providing potential pain and anxiety relief, among many others.
THC is why cannabis is illegal on the federal level. CBD, on the other hand, is entirely legal in all 50 states.
CBD does NOT get you high.
That is a common misconception. Its effects are subtle, non-intrusive, and work in the background.
In other words, it may relieve pain, reduce inflammation, soothe muscle soreness, improve mood, calm anxiety, heighten cognition, and much more– without any psychoactive effects.
Those who take Full Spectrum CBD will tell you the only thing you will feel is that your symptoms are relieved. Don’t expect a “buzz.” Expect relief.
CBD or cannabidiol is derived from “hemp.” Hemp is not the same as marijuana. To the untrained eye, the two plants look nearly the same. Both are considered cannabis– but their morphology, chemical makeup, and uses are very different. Hemp is a strain specifically grown primarily devoid of the intoxicating compounds found in marijuana.
You will often see the phrase “industrial hemp” because hemp can be used to make various industrial products. Paper, textiles, clothing, shoes, food, rope, bioplastics, insulation, and biofuel can all be made with hemp.
Benefits of CBD
Hemp’s versatility is pretty miraculous, especially for the endocannabinoid system. And given that it is totally legal in the US, these uses can all be explored to their fullest potential with complete legal compliance. This also means that it can be fully and comprehensively regulated.
Therefore, when you buy a product infused with CBD (and there are MANY), you can rest assured that a reputable third party has regulated it for safety, purity, and potency.
These certifications are available to the public for nearly all CBD Oil products, and you should always look for proof that its production has been regulated. We are very vigilant in assuring our products are vetted and safe. We encourage your vigilance with anything you put in your body, CBD or not.
Effects of CBD
That’s not to say CBD is risky– quite the opposite. CBD is regarded as one of the most natural and safe remedies for the mind and body, with little to no side effects. It is entirely non-addictive, non-habit-forming, and works naturally in your body to provide non-intrusive and potentially comprehensive relief.
You can ingest CBD in many forms, such as:
Oral Concentrates: the most potent form of ingestion. This includes tinctures (a viscous fluid dropped sublingually), oral sprays, and drink mixtures, to name a few.
Edibles: are also very popular, such as infused gummy candy and chocolate. See our full line of CBD Gummies.
Skincare: utilizes CBD in lotions, balms, salves, and more to provide nourishing and soothing relief to the skin.
Haircare: including shampoos and conditioners to invigorate your hair with hemp and leave it radiant and healthy.
Pet products: so your furry little friends can enjoy all of the same benefits you can. This includes tinctures, oral sprays, and treats– all the same human products formulated specifically for pets.
. and many more! Browse our selection of best CBD for a complete catalog of diverse products that utilize CBD in nearly every form imaginable.
CBD Oil Store
All our products contain high amounts of CBD (Cannabidiol), which is a cannabis compound that is known for its beneficial effects.
Soothe your sore muscles with our powerful topical cream.
The best of Nature enhanced by Science.
Premium botanical blends infused with full spectrum CBD oil.
CBNight Water Soluble CBN Oil
CBD Cigarettes 1 Pack
CBDA CBGA Extract – Comprehensive Immune Support (30mL)
US Hemp Roundtable
As you are well aware, the primary policy challenging facing the hemp-derived CBD industry is guidance issued by FDA, opining that it is illegal for CBD to be introduced into interstate commerce as a food additive or dietary supplement. While the FDA has announced that it will unveil its timetable for action this fall, it could be many months before they issue a formal regulation.
Two of our hemp champions in Congress, Reps. Chellie Pingree (D-ME) and James Comer (R-KY) have joined forces to do something about it. And they need your help to rally other Congressmen to join the fight.
Yesterday, Reps. Pingree and Comer sent all members of the US House of Representatives a “Dear Colleague” letter, asking them to co-sign a letter that urges the FDA to issue formal “enforcement discretion” on the sale of hemp CBD products. This would mean that the FDA would formally stand down on any enforcement of its troublesome anti-CBD guidance. Such a policy would remove significant risk from the sale of CBD products.
Please email your Congressman TODAY, urging him or her to co-sign the Pingree/Comer FDA letter.
As always, we have made it super easy for you to contact your Representative. Simply click onto our online portal, with your email and zip code, and a message will automatically populate to be sent to your Congressman. Please feel free to personalize the message to explain why hemp CBD is important to you, your family, your company, or your farm.
This morning, Senate Majority Leader Mitch McConnell – after consulting closely with the US Hemp Roundtable — has introduced legislation that would require the FDA to issue formal “enforcement discretion” on the sale of hemp CBD products.
This is a Big Frickin’ Deal. And we need your help to get this passed.
As discussed more fully last week, a primary policy challenge facing the hemp CBD industry has been FDA’s guidance that it is illegal for CBD to be introduced into interstate commerce as a food additive or dietary supplement. While the FDA has announced that it will unveil its timetable to take action toward full legalization this fall, it could be many months before they issue a formal regulation.
Today, the US Senate Appropriations Subcommittee on Agriculture will “mark up” language submitted by Senator McConnell that would require the FDA to formally stand down on any enforcement of its troublesome anti-CBD guidance. Specifically, the language (linked here) would require FDA to:
-Within 90 days, provide Congress a report outlining its efforts to develop an enforcement discretion policy on hemp CBD;
-Within 120 days, issue its formal enforcement discretion policy on hemp CBD;
-Keep the enforcement discretion policy in effect until the agency has implemented its final regulatory process; and
-Ensure that going forward, CBD manufacturers would be able share safety data through existing FDA notification procedures to be fully compliant with federal law and policy.
In the short run, the McConnell language would help lift the current regulatory cloud that’s been discouraging financial institutions to work with CBD companies, and that’s encouraged some local government officials to suggest that CBD is illegal in their state. In the long run, it would set forward a fair and expeditious path for hemp CBD products to be formally recognized as safe and legal as a matter of federal law.
The bill will be marked up by the full Senate Appropriations Committee on Thursday, and could go to the full Senate soon.
That’s why we need you TODAY to email your US Senators to encourage them to support McConnell’s language requiring FDA to stand down on hemp CBD.
Please use our online portal to email your Senator today to support the McConnell plan. And while you are there, please encourage your Representative to sign onto the Pingree/Comer letter to the FDA discussed here last week.